L'équipe du département de pharmacologie

FIELDS

CONTACT

 

 

 

Université Bordeaux 2 CHU de Bordeaux INSERM
Département Hospitalo-Universitaire de Pharmacologie de Bordeaux
fren
  • Home
  • Publications in 2019

PUBLICATIONS in 2019

Publications' last update : 2021-02-22

  1. Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug-drug interactions through the FDA adverse event reporting system
    Acta Diabetol. 2019 (57-1) 71-80
    Antonazzo IC, Poluzzi E, Forcesi E, Salvo F, Pariente A, Marchesini G, De Ponti F, Raschi E.
     PubMed citation

  2. Signal of potentially protective drug-drug interactions from spontaneous reporting systems: proceed with caution
    Acta Diabetol. 2019 (57-1) 115-116
    Antonazzo IC, Poluzzi E, Forcesi E, Salvo F, Pariente A, Marchesini G, De Ponti F, Raschi E.
     PubMed citation

  3. Pharmacology and social media: Potentials and biases of web forums for drug mention analysis-case study of France
    Health Informatics J. 2019 (ahead of print)
    Audeh B, Calvier FE, Bellet F, Beyens MN, Pariente A, Lillo-Le Louet A, Bousquet C.
     PubMed citation

  4. Pharmacoepidemiology, the new paradigm of drug evaluation
    Therapie. 2019 (74-2) 167-168
    Bégaud B, Montastruc JL.
     PubMed citation

  5. Pharmacoepidemiology of statins
    Therapie. 2019 (74-2) 261-269
    Bezin J, Moore N.
     PubMed citation

  6. Real-life benefits of statins for cardiovascular prevention in elderly subjects: a population-based cohort study
    Am J Med. 2019 (132-6) 740-748
    Bezin J, Moore N, Mansiaux Y, Steg PG, Pariente A.
     PubMed citation

  7. The Reply
    Am J Med. 2019 (132-7) e622
    Bezin J, Moore N, Steg PG, Pariente A.
     PubMed citation

  8. Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
    Am J Cardiovasc Drugs. 2019 (ahead of print)
    Blin P, Dureau-Pournin C, Bénichou J, Cottin Y, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.
     PubMed citation

  9. Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation
    Stroke. 2019 (50-9) 2469-2476
    Blin P, Fauchier L, Dureau-Pournin C, Sacher F, Dallongeville J, Bernard MA, Lassalle R, Droz-Perroteau C, Moore N.
     PubMed citation

  10. Pharmacological treatment patterns in heart failure: a population-based cohort study
    Eur J Clin Pharmacol. 2019 (ahead of print)
    Bosco-Lévy P, Favary C, Jové J, Lassalle R, Moore N, Droz-Perroteau C.
     PubMed citation

  11. Safety of levonorgestrel 52mg intrauterine system compared to copper intrauterine device: a population-based cohort study
    Contraception. 2019 (ahead of print)
    Bosco-Lévy P, Gouverneur A, Langlade C, Miremont G, Pariente A.
     PubMed citation

  12. Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study
    Arch Cardiovasc Dis. 2019 (113-1) 9-21
    Bretagne M, Lebrun-Vignes B, Pariente A, Shaffer CM, Malouf GG, Dureau P, Potey C, Funck-Brentano C, Roden DM, Moslehi JJ, Salem JE.
     PubMed citation

  13. What we know about media communication on antibiotics and antimicrobial resistance: A systematic review of the scientific literature
    Patient Educ Couns. 2019 (102-8) 1427-14
    Catalán-Matamoros D, Pariente A, Elías-Pérez C.
     PubMed citation

  14. Comparative study of hypoglycaemia induced by opioids. Is it a class effect?
    Expert Opin Drug Saf. 2019 (18-10) 987-992
    Chrétien B, Dolladille C, Hamel-Sénécal L, Sassier M, Faillie JL, Miremont-Salamé G, Lelong-Boulouard V, Le Boisselier R, Fedrizzi S, Alexandre J, Humbert X.
     PubMed citation

  15. Reply to Letter to the Editor: hypoglycaemia and treatment with opioids
    Expert Opin Drug Saf. 2019 (18-12) 1265-1266
    Chrétien B, Dolladille C, Hamel-Sénécal L, Sassier M, Faillie JL, Miremont-Salamé G, Lelong-Boulouard V, Le Boisselier R, Fedrizzi S, Alexandre J, Humbert X.
     PubMed citation

  16. The sustainable impact of an educational approach to improve the appropriateness of laboratory test orders in the ICU
    PLoS One. 2019 (14-5) e0214802
    Clouzeau B, Caujolle M, San-Miguel A, Pillot J, Gazeau N, Tacaille C, Dousset V, Bazin F, Vargas F, Hilbert G, Molimard M, Gruson D, Boyer A.
     PubMed citation

  17. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology
    Therapie. 2019 (74-2) 279-288
    Conte C, Vaysse C, Bosco P, Noize P, Fourrier-Reglat A, Despas F, Lapeyre-Mestre M.
     PubMed citation

  18. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: a retrospective database study in France
    Allergy. 2019 (74-7) 1317-1326
    Devillier P, Molimard M, Ansolabehere X, Bardoulat I, Coulombel N, Maurel F, Le Jeunne P, Demoly P.
     PubMed citation

  19. Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI
    Therapie. 2019 (74-4) 459-468
    Droz-Perroteau C, Blin P, Dureau-Pournin C, Thomas D, Danchin N, Tricoire J, Paillard F, Hercberg S, Guize L, Guiard E, Maïzi H, Bernard MA, Bénichou J, Moore N.
     PubMed citation

  20. Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
    Europace. 2019 (ahead of print)
    Fauchier L, Blin P, Sacher F, Dureau-Pournin C, Bernard MA, Lassalle R, Droz-Perroteau C, Dallongeville J, Moore N.
     PubMed citation

  21. Secondary stroke prevention: a population-based cohort study on anticoagulation and antiplatelet treatments, and the risk of death or recurrence
    Clin Pharmacol Ther. 2019 (ahead of print)
    Faure M, Castilloux AM, Lillo-Le-Louet A, Bégaud B, Moride Y.
     PubMed citation

  22. Treatment Modalities and Survival in Older Adults with Metastatic Colorectal Cancer in Real Life
    J Am Geriatr Soc. 2019 (67-5) 913-919
    Gouverneur A, Bezin J, Jové J, Bosco-Lévy P, Fourrier-Réglat A, Noize P.
     PubMed citation

  23. Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study
    Drug Saf. 2019 (42-8) 993-1003
    Guiard E, Lelievre B, Rouyer M, Zerbib F, Diquet B, Mégraud F, Tison F, Bignon E, Lassalle R, Droz-Perroteau C, Moore N, Blin P.
     PubMed citation

  24. Association of Valproic Acid With Central Sleep Apnea Syndrome: Two Case Reports
    J Clin Psychopharmacol. 2019 (39-6) 681-684
    Guichard K, Micoulaud-Franchi JA, McGonigal A, Coulon P, Sureau C, Ghorayeb I, Salvo F, Philip P.
     PubMed citation

  25. A review of Algerian medicinal plants used in the treatment of diabetes
    J Ethnopharmacol. 2019 (238) 111841
    Hamza N, Berke B, Umar A, Cheze C, Gin H, Moore N.
     PubMed citation

  26. Incidence of Direct Oral Anticoagulant use in patients with non-valvular atrial fibrillation and characteristics of users in six European countries (2008-2015): A cross-national drug utilization study
    Br J Clin Pharmacol. 2019 (ahead of print)
    Ibáñez L, Sabaté M, Vidal X, Ballarin E, Rottenkolber M, Schmiedl S, Heeke A, Huerta C, Martin Merino E, Montero D, Leon-Muñoz LM, Gasse C, Moore N, Droz C, Lassalle R, Aakjaer M, Andersen M, De Bruin ML, Groenwold R, van den Ham R, Souverein P, Klungel O, Gardarsdottir H.
     PubMed citation

  27. Adverse events reported for levonorgestrel-releasing IUD Mirena® in France and impact of media coverage
    Br J Clin Pharmacol. 2019 (ahead of print)
    Langlade C, Gouverneur A, Bosco-Lévy P, Gouraud A, Pérault-Pochat MC, Béné J, Miremont-Salamé G, Pariente A; French Network of Pharmacovigilance Centres.
     PubMed citation

  28. Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
    Front Pharmacol. 2019 (10) 265
    Létinier L, Cossin S, Mansiaux Y, Arnaud M, Salvo F, Bezin J, Thiessard F, Pariente A.
     PubMed citation

  29. Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study
    Ophthalmic Res. 2019 (62-2) 101-110
    Massin P, Creuzot-Garcher C, Kodjikian L, Girmens JF, Delcourt C, Fajnkuchen F, Glacet-Bernard A, Guillausseau PJ, Ponthieux A, Blin P, Grelaud A.
     PubMed citation

  30. Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016
    BMJ Open. 2019 (9-4) e026645
    Maura G, Billionnet C, Drouin J, Weill A, Neumann A, Pariente A.
     PubMed citation

  31. Pharmacovigilance - The next chapter
    Therapie. 2019 (74-6) 557-567
    Moore N, Berdaï D, Blin P, Droz C.
     PubMed citation

  32. Pharmacoepidemiology
    Handb Exp Pharmacol. 2019 (260) 433-451
    Moore N, Blin P, Droz C.
     PubMed citation

  33. Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period
    Vaccine. 2019 (ahead of print)
    Mouchet J, Bégaud B.
     PubMed citation

  34. The French Levothyrox® crisis: We did the best we could but…
    Therapie. 2019 (74-3) 431-435
    Mouly S, Roustit M, Bagheri H, Perault-Pochat MC, Molimard M, Bordet R.
     PubMed citation

  35. Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria
    Ther Adv Drug Saf. 2019 (10) 2042098618816279
    Opadeyi AO, Fourrier-Réglat A, Isah AO.
     PubMed citation

  36. Appropriateness of psychotropic drug prescriptions in the elderly: structuring tools based on data extracted from the hospital information system to understand physician practices
    BMC Health Serv Res. 2019 (19-1) 272
    Petit-Monéger A, Jouhet V, Thiessard F, Berdaï D, Noize P, Gilleron V, Caridade G, Salmi LR, Saillour-Glénisson F.
     PubMed citation

  37. Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections
    JAMA. 2019 (321-6) 613
    Prevel R, Berdaï D, Boyer A.
     PubMed citation

  38. Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction
    Br J Clin Pharmacol. 2019 (ahead of print)
    Puel V, Théophile H, Godard I, Raymond N, Miremont-Salamé G, Gosse P, Pépin JL, Pariente A.
     PubMed citation

  39. Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort
    Br J Cancer. 2019 (121-12) 1001-1008
    Rouyer M, Oudard S, Joly F, Fizazi K, Tubach F, Jove J, Lacueille C, Lamarque S, Guiard E, Balestra A, Droz-Perroteau C, Fourrier-Reglat A, Moore N; FUJI Investigators.
     PubMed citation

  40. Health administrative data enrichment using cohort information: Comparative evaluation of methods by simulation and application to real data
    2019. 2019 (14-1) e0211118
    Silenou BC, Avalos M, Helmer C, Berr C, Pariente A, Jacqmin-Gadda H.
     PubMed citation

  41. Methods in pharmacoepidemiology
    Therapie. 2019 (74-2) 187-197
    Sommet A, Pariente A.
     PubMed citation

  42. Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure
    J Affect Disord. 2019 (257) 412-42
    Tournier M, Neumann A, Pambrun E, Weill A, Chaffiol JP, Alla F, Bégaud B, Maura G, Verdoux H.
     PubMed citation

  43. Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study
    BMJ Open. 2019 (9-11) e033040
    Villa A, Molimard M, Bignon E, Martinez B, Rouyer M, Mathoulin-Pelissier S, Baldi I, Verdun-Esquer C, Canal-Raffin M.
     PubMed citation